{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:52:23Z","timestamp":1789685543548,"version":"4.0.1"},"reference-count":97,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Endocrine disorders in survivors of childhood, adolescent, and young adult (CAYA) cancers are associated with substantial adverse physical and psychosocial effects. To improve appropriate and timely endocrine screening and referral to a specialist, the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) aims to develop evidence and expert consensus-based guidelines for healthcare providers that harmonize recommendations for surveillance of endocrine disorders in CAYA cancer survivors. Existing IGHG surveillance recommendations for premature ovarian insufficiency, gonadotoxicity in males, fertility preservation, and thyroid cancer are summarized. For hypothalamic-pituitary (HP) dysfunction, new surveillance recommendations were formulated by a guideline panel consisting of 42 interdisciplinary international experts. A systematic literature search was performed in MEDLINE (through PubMed) for clinically relevant questions concerning HP dysfunction. Literature was screened for eligibility. Recommendations were formulated by drawing conclusions from quality assessment of all evidence, considering the potential benefits of early detection and appropriate management. Healthcare providers should be aware that CAYA cancer survivors have an increased risk for endocrine disorders, including HP dysfunction. Regular surveillance with clinical history, anthropomorphic measures, physical examination, and laboratory measurements is recommended in at-risk survivors. When endocrine disorders are suspected, healthcare providers should proceed with timely referrals to specialized services. These international evidence-based recommendations for surveillance of endocrine disorders in CAYA cancer survivors inform healthcare providers and highlight the need for long-term endocrine follow-up care in subgroups of survivors and elucidate opportunities for further research.<\/jats:p>","DOI":"10.1210\/endrev\/bnab040","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T10:58:59Z","timestamp":1640689139000},"page":"794-823","source":"Crossref","is-referenced-by-count":64,"title":["Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors"],"prefix":"10.1210","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-2336","authenticated-orcid":false,"given":"Laura","family":"van Iersel","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital, University Medical Center Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee L","family":"Mulder","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Denzer","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics & Adolescent Medicine, Ulm University Medical Center , Ulm , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie E","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Boston Children\u2019s Hospital , Boston, MA , USA"},{"name":"Dana Farber\/Boston Children\u2019s Cancer and Blood Disorder Center , Boston, MA , USA"},{"name":"Department of Pediatrics, Harvard Medical School , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A","family":"Spoudeas","sequence":"additional","affiliation":[{"name":"The London Centre for Pediatric Endocrinology & Diabetes , London , UK"},{"name":"Great Ormond Street Hospital for Children NHS Foundation Trust , London , UK"},{"name":"The London Centre for Pediatric Endocrinology and Diabetes, University College London Hospital , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4394-0070","authenticated-orcid":false,"given":"Lillian R","family":"Meacham","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine; Atlanta, GA, USA"},{"name":"Aflac Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta , Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Sugden","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette Y N","family":"Schouten-van Meeteren","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelco W","family":"Hoving","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-7531","authenticated-orcid":false,"given":"Roger J","family":"Packer","sequence":"additional","affiliation":[{"name":"The Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children\u2019s National Health System , Washington, DC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogol","family":"Mostoufi-Moab","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Children\u2019s Hospital of Philadelphia, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline M","family":"Stades","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Medical Center Utrecht, Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dannis","family":"van Vuurden","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert O","family":"Janssens","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands"},{"name":"Department of Radiation Oncology, University Medical Center Utrecht, Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Thomas-Teinturier","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Group, Center for Research in Epidemiology and Population Health (CESP), Universit\u00e9 Paris-Sud XI , Villejuif , France"},{"name":"Department of Pediatric Endocrinology, APHP, H\u00f4pitaux Paris-Sud, Site Bicetre , Le Kremlin-Bicetre , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust , Leeds , UK"},{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-4585","authenticated-orcid":false,"given":"Natascia","family":"Di Iorgi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Istituto Giannina Gaslini, University of Genova , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J C M M","family":"Neggers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology\/BMT, Children\u2019s Mercy Hospitals and Clinics , Kansas City, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Toogood","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Queen Elizabeth Hospital Birmingham , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Queen Elizabeth Hospital Birmingham , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Follin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sk\u00e5ne University Hospital , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Bardi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Kepler Universit\u00e4tsklinikum , Linz , Austria"},{"name":"St Anna Childrens Hospital , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilibeth","family":"Torno","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, CHOC Children\u2019s Hospital\/University of California , Orange, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Patterson","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine; Atlanta, GA, USA"},{"name":"Aflac Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta , Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Morsellino","sequence":"additional","affiliation":[{"name":"DOPO Clinic, Division of Pediatric Hematology\/Oncology, IRCCS Istituto Giannina Gaslini , Genova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Sommer","sequence":"additional","affiliation":[{"name":"Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern , Bern , Switzerland"},{"name":"Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Bern University Hospital, University of Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C","family":"Clement","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Amsterdam University Medical Center, location VU University Medical Center , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deokumar","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St. Jude Children\u2019s Research Hospital , Memphis TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie E","family":"Kiserud","sequence":"additional","affiliation":[{"name":"Department of Oncology, National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital , Oslo , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Hospital Universitario de Mostoles , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Scheinemann","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Kantonsspital Aarau , Aarau , Switzerland"},{"name":"Division of Pediatric Hematology\/Oncology, University Children\u2019s Hospital Basel and University of Basel , Basel , Switzerland"},{"name":"Division of Pediatric Hematology\/Oncology, McMaster Children\u2019s Hospital and McMaster University , Hamilton, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripriya","family":"Raman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Children\u2019s Hospital of Pittsburgh , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C J","family":"Yuen","sequence":"additional","affiliation":[{"name":"Department of Neuroendocrinology and Neurosurgery, Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine , Phoenix, AZ , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Hamish","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Paediatric Oncology, Royal Hospital for Sick Children , Edinburgh , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis S","family":"Constine","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology and Pediatrics, University of Rochester Medical Center , Rochester, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Skinner","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Haematology\/Oncology, Great North Children\u2019s Hospital and Newcastle University Centre for Cancer , Newcastle upon Tyne , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, and Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontien C M","family":"Kremer","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands"},{"name":"Department of Pediatric Oncology, Emma Children\u2019s Hospital, Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Chemaitilly","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6773-6931","authenticated-orcid":false,"given":"Hanneke M","family":"van Santen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children\u2019s Hospital, University Medical Center Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"issue":"6","key":"2022092617291736600_CIT0001","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ejca.2008.11.042","article-title":"Survival of European children and young adults with cancer diagnosed 1995-2002","volume":"45","author":"Gatta","year":"2009","journal-title":"Eur J Cancer."},{"key":"2022092617291736600_CIT0002","volume-title":"SEER Cancer Statistics Review, 1975\u20132013.","author":"Howlader","year":"2016"},{"issue":"1","key":"2022092617291736600_CIT0003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat Rev Cancer."},{"issue":"27","key":"2022092617291736600_CIT0004","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2016.66.6545","article-title":"Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor study","volume":"34","author":"Mostoufi-Moab","year":"2016","journal-title":"J Clin Oncol."},{"issue":"12","key":"2022092617291736600_CIT0005","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"36","key":"2022092617291736600_CIT0006","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1200\/JCO.2016.67.5025","article-title":"Prevalence and risk factors of early endocrine disorders in childhood brain tumor survivors: a nationwide, multicenter study","volume":"34","author":"Clement","year":"2016","journal-title":"J Clin Oncol."},{"issue":"2","key":"2022092617291736600_CIT0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000493943","article-title":"Childhood cancer treatments and associated endocrine late effects: a concise guide for the pediatric endocrinologist","volume":"91","author":"Chemaitilly","year":"2019","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"2022092617291736600_CIT0008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol."},{"issue":"12","key":"2022092617291736600_CIT0009","doi-asserted-by":"crossref","first-page":"e28723","DOI":"10.1002\/pbc.28723","article-title":"Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma","volume":"67","author":"van Iersel","year":"2020","journal-title":"Pediatr Blood Cancer."},{"issue":"11","key":"2022092617291736600_CIT0010","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1210\/jc.2019-00627","article-title":"Endocrine and metabolic disorders in survivors of childhood cancers and health-related quality of life and physical activity","volume":"104","author":"Pradhan","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092617291736600_CIT0011","author":"Children\u2019s Oncology Group."},{"key":"2022092617291736600_CIT0012","author":"Dutch Childhood Oncology Group.","year":"2014"},{"key":"2022092617291736600_CIT0013","author":"Skinner"},{"key":"2022092617291736600_CIT0014","author":"Scottish Intercollegiate Guidelines Network."},{"issue":"4","key":"2022092617291736600_CIT0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/pbc.24445","article-title":"A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"60","author":"Kremer","year":"2013","journal-title":"Pediatr Blood Cancer."},{"issue":"2","key":"2022092617291736600_CIT0016","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/S1470-2045(17)30026-8","article-title":"Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","volume":"18","author":"Skinner","year":"2017","journal-title":"Lancet Oncol."},{"key":"2022092617291736600_CIT0017","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.11.005","article-title":"Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","volume":"63","author":"Clement","year":"2018","journal-title":"Cancer Treat Rev."},{"issue":"28","key":"2022092617291736600_CIT0018","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","article-title":"Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium","volume":"34","author":"van Dorp","year":"2016","journal-title":"J Clin Oncol."},{"issue":"2","key":"2022092617291736600_CIT0019","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol."},{"issue":"2","key":"2022092617291736600_CIT0020","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S1470-2045(20)30582-9","article-title":"Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol."},{"issue":"7","key":"2022092617291736600_CIT0021","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022092617291736600_CIT0022","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S2213-8587(15)00039-X","article-title":"Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults","volume":"3","author":"Anderson","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9744","key":"2022092617291736600_CIT0023","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","article-title":"Primary ovarian insufficiency","volume":"376","author":"De Vos","year":"2010","journal-title":"Lancet."},{"issue":"2","key":"2022092617291736600_CIT0024","doi-asserted-by":"crossref","first-page":"e1002","DOI":"10.1210\/clinem\/dgaa797","article-title":"Beyond premature ovarian insufficiency: staging reproductive aging in adolescent and young adult cancer survivors","volume":"106","author":"Medica","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022092617291736600_CIT0025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jamaoncol.2018.4420","article-title":"Erectile dysfunction in male survivors of childhood cancer","volume":"4","author":"van Iersel","year":"2018","journal-title":"JAMA Oncol."},{"issue":"6","key":"2022092617291736600_CIT0026","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jsxm.2016.03.367","article-title":"Erectile dysfunction in male survivors of childhood cancer: a report from the Childhood Cancer Survivor study","volume":"13","author":"Ritenour","year":"2016","journal-title":"J Sex Med."},{"issue":"22","key":"2022092617291736600_CIT0027","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA."},{"issue":"2","key":"2022092617291736600_CIT0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/neuonc\/noq178","article-title":"Survival and long-term health and cognitive outcomes after low-grade glioma","volume":"13","author":"Armstrong","year":"2011","journal-title":"Neuro Oncol."},{"issue":"2","key":"2022092617291736600_CIT0029","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199301143280203","article-title":"Hypothalamic-pituitary dysfunction after radiation for brain tumors","volume":"328","author":"Constine","year":"1993","journal-title":"N Engl J Med."},{"issue":"8","key":"2022092617291736600_CIT0030","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1210\/jc.2003-030366","article-title":"Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement","volume":"88","author":"Gleeson","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022092617291736600_CIT0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"7454","key":"2022092617291736600_CIT0032","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ."},{"issue":"24","key":"2022092617291736600_CIT0033","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1161\/01.CIR.0000079017.53579.9C","article-title":"American College of Cardiology\/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project","volume":"107","author":"Gibbons","year":"2003","journal-title":"Circulation."},{"issue":"10","key":"2022092617291736600_CIT0034","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1210\/jc.2015-2028","article-title":"Neuroendocrine morbidity after pediatric optic gliomas: a longitudinal analysis of 166 children over 30 years","volume":"100","author":"Gan","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022092617291736600_CIT0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000327584","article-title":"Endocrine outcome in long-term survivors of childhood brain tumors","volume":"76","author":"Shalitin","year":"2011","journal-title":"Horm Res Paediatr."},{"issue":"2","key":"2022092617291736600_CIT0036","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3476(05)80487-1","article-title":"Dose dependency of time of onset of radiation-induced growth hormone deficiency","volume":"118","author":"Clayton","year":"1991","journal-title":"J Pediatr."},{"issue":"36","key":"2022092617291736600_CIT0037","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J Clin Oncol."},{"issue":"2","key":"2022092617291736600_CIT0038","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2000.01079.x","article-title":"Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study","volume":"53","author":"Schmiegelow","year":"2000","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"2022092617291736600_CIT0039","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2002-021994","article-title":"Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022092617291736600_CIT0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/nov302","article-title":"Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma","volume":"18","author":"Eaton","year":"2016","journal-title":"Neuro Oncol."},{"issue":"6","key":"2022092617291736600_CIT0041","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22120","article-title":"Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia","volume":"107","author":"Gurney","year":"2006","journal-title":"Cancer."},{"issue":"12","key":"2022092617291736600_CIT0042","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bmt.1705374","article-title":"Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence","volume":"37","author":"Shalitin","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"2022092617291736600_CIT0043","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/cen.12773","article-title":"Growth hormone deficiency after childhood bone marrow transplantation with total body irradiation: interaction with adiposity and age","volume":"83","author":"Davis","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2022092617291736600_CIT0044","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2265.1998.00438.x","article-title":"Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood","volume":"48","author":"Brennan","year":"1998","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022092617291736600_CIT0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MD.0b013e31812f864d","article-title":"A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation","volume":"86","author":"Leung","year":"2007","journal-title":"Medicine (Baltimore)."},{"issue":"12","key":"2022092617291736600_CIT0046","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/BF02072067","article-title":"Growth and endocrine disorders in optic glioma","volume":"149","author":"Brauner","year":"1990","journal-title":"Eur J Pediatr."},{"key":"2022092617291736600_CIT0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2015.10.064","article-title":"Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma","volume":"54","author":"Clement","year":"2016","journal-title":"Eur J Cancer."},{"issue":"5","key":"2022092617291736600_CIT0048","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3171\/jns.1991.74.5.0743","article-title":"Growth hormone deficiency following radiation therapy of primary brain tumors in children","volume":"74","author":"Kanev","year":"1991","journal-title":"J Neurosurg."},{"issue":"7","key":"2022092617291736600_CIT0049","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","article-title":"Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial","volume":"26","author":"Laughton","year":"2008","journal-title":"J Clin Oncol."},{"issue":"3","key":"2022092617291736600_CIT0050","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood-2004-07-2528","article-title":"Final adult height of patients who received hematopoietic cell transplantation in childhood","volume":"105","author":"Sanders","year":"2005","journal-title":"Blood."},{"issue":"5","key":"2022092617291736600_CIT0051","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cen.12815","article-title":"Endocrine sequelae beyond 10 years in survivors of medulloblastoma","volume":"83","author":"Uday","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2022092617291736600_CIT0052","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.medici.2014.10.006","article-title":"Early development of endocrine and metabolic consequences after treatment of central nervous system tumors in children","volume":"50","author":"Ramanauskien\u0117","year":"2014","journal-title":"Medicina (Kaunas)."},{"issue":"22","key":"2022092617291736600_CIT0053","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1200\/JCO.2008.21.2738","article-title":"Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol."},{"issue":"3","key":"2022092617291736600_CIT0054","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","article-title":"Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study","volume":"17","author":"Yock","year":"2016","journal-title":"Lancet Oncol."},{"issue":"4","key":"2022092617291736600_CIT0055","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ijrobp.2012.01.049","article-title":"Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors","volume":"84","author":"Hua","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"6","key":"2022092617291736600_CIT0056","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/acta.0.1290511","article-title":"Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation","volume":"129","author":"Sklar","year":"1993","journal-title":"Acta Endocrinol (Copenh)."},{"issue":"2","key":"2022092617291736600_CIT0057","first-page":"71","article-title":"Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation","volume":"50","author":"Tillmann","year":"1998","journal-title":"Horm Res."},{"issue":"8","key":"2022092617291736600_CIT0058","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1210\/jc.2018-01204","article-title":"Diagnosis of GH deficiency as a late effect of radiotherapy in survivors of childhood cancers","volume":"103","author":"Sfeir","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022092617291736600_CIT0059","first-page":"4472","article-title":"Diagnosis of hidden central hypothyroidism in survivors of childhood cancer","volume":"84","author":"Rose","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022092617291736600_CIT0060","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1210\/jc.2005-1593","article-title":"Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors","volume":"90","author":"Darzy","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022092617291736600_CIT0061","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/pbc.22208","article-title":"Adrenal function testing in pediatric cancer survivors","volume":"53","author":"Patterson","year":"2009","journal-title":"Pediatr Blood Cancer."},{"issue":"4","key":"2022092617291736600_CIT0062","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2007.02930.x","article-title":"Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood","volume":"67","author":"Bakker","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022092617291736600_CIT0063","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40618-014-0179-1","article-title":"GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution","volume":"38","author":"Brignardello","year":"2015","journal-title":"J Endocrinol Invest."},{"issue":"9","key":"2022092617291736600_CIT0064","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"13","key":"2022092617291736600_CIT0065","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1200\/JCO.2002.09.142","article-title":"Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia","volume":"20","author":"Leung","year":"2002","journal-title":"J Clin Oncol."},{"issue":"9","key":"2022092617291736600_CIT0066","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022092617291736600_CIT0067","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022092617291736600_CIT0068","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor study","volume":"87","author":"Sklar","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022092617291736600_CIT0069","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/EJE-12-0967","article-title":"Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS","volume":"168","author":"Woodmansee","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2022092617291736600_CIT0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/JPEM.1997.10.1.41","article-title":"Growth hormone treatment in irradiated children with brain tumors","volume":"10","author":"Corrias","year":"1997","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"6842","key":"2022092617291736600_CIT0071","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/bmj.304.6842.1601","article-title":"Growth hormone and tumour recurrence","volume":"304","author":"Ogilvy-Stuart","year":"1992","journal-title":"BMJ."},{"issue":"2","key":"2022092617291736600_CIT0072","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1200\/JCO.2001.19.2.480","article-title":"Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control","volume":"19","author":"Packer","year":"2001","journal-title":"J Clin Oncol."},{"issue":"12","key":"2022092617291736600_CIT0073","first-page":"4444","article-title":"Growth hormone treatment of children with brain tumors and risk of tumor recurrence","volume":"85","author":"Swerdlow","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022092617291736600_CIT0074","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society","volume":"85","author":"Growth Hormone Research Society.","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2022092617291736600_CIT0075","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022092617291736600_CIT0076","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022092617291736600_CIT0077","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr."},{"issue":"6","key":"2022092617291736600_CIT0078","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022092617291736600_CIT0079","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2022092617291736600_CIT0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000491388","article-title":"2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism","volume":"7","author":"Persani","year":"2018","journal-title":"Eur Thyroid J."},{"issue":"5","key":"2022092617291736600_CIT0081","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022092617291736600_CIT0082","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/archdischild-2016-311372","article-title":"Hormone supplementation for pubertal induction in girls","volume":"102","author":"Matthews","year":"2017","journal-title":"Arch Dis Child."},{"issue":"4","key":"2022092617291736600_CIT0083","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics."},{"issue":"8","key":"2022092617291736600_CIT0084","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2018-01205","article-title":"GH therapy in childhood cancer survivors: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022092617291736600_CIT0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cen.12964","article-title":"Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes","volume":"84","author":"Chemaitilly","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022092617291736600_CIT0086","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2006.02582.x","article-title":"Presentation and evolution of organic central precocious puberty according to the type of CNS lesion","volume":"65","author":"Trivin","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"8","key":"2022092617291736600_CIT0087","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022092617291736600_CIT0088","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1210\/jc.2005-2227","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"91","author":"Molitch","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022092617291736600_CIT0089","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ecl.2014.10.003","article-title":"Pitfalls of insulin-like growth factor-I and growth hormone assays","volume":"44","author":"Junnila","year":"2015","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"11","key":"2022092617291736600_CIT0090","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Growth Hormone Deficiency in adults and patients transitioning from pediatric to adult care","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr Pract."},{"issue":"3","key":"2022092617291736600_CIT0091","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563216687335","article-title":"Measuring cortisol in serum, urine and saliva\u2014are our assays good enough?","volume":"54","author":"El-Farhan","year":"2017","journal-title":"Ann Clin Biochem."},{"issue":"6","key":"2022092617291736600_CIT0092","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022092617291736600_CIT0093","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1210\/jc.2019-00539","article-title":"Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022092617291736600_CIT0094","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11102-008-0130-6","article-title":"Pathophysiology of hypopituitarism in the setting of brain injury","volume":"15","author":"Dusick","year":"2012","journal-title":"Pituitary."},{"issue":"3","key":"2022092617291736600_CIT0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/cen.13063","article-title":"Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review","volume":"85","author":"Joshi","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2022092617291736600_CIT0096","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0360-3016(02)02888-2","article-title":"Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function","volume":"54","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"36","key":"2022092617291736600_CIT0097","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1200\/JCO.2016.70.1847","article-title":"Hypothalamic-pituitary axis dysfunction in survivors of childhood CNS tumors: importance of systematic follow-up and early endocrine consultation","volume":"34","author":"Chemaitilly","year":"2016","journal-title":"J Clin Oncol."}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnab040\/41952408\/bnab040.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/43\/5\/794\/46051858\/bnab040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/43\/5\/794\/46051858\/bnab040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:48:13Z","timestamp":1699984093000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/43\/5\/794\/6432595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":97,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,11,20]]},"published-print":{"date-parts":[[2022,9,26]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnab040","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2021,11,20]]}}}